Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis

Area of Science:

• Immunology
• Pharmacology
• Critical Care Medicine

Background:

• Sepsis involves a dysregulated immune response, with norepinephrine commonly used for septic shock.
• Norepinephrine's potential to exacerbate immune dysregulation and impair host defense requires investigation.
• Understanding vasopressor effects on immunity is crucial for optimizing sepsis management.

Purpose of the Study:

• To investigate the immunomodulatory effects of norepinephrine and vasopressin.
• To compare the impact of norepinephrine and vasopressin on host defense mechanisms.
• To assess the clinical correlation between norepinephrine use, cytokine profiles, and beta-blocker administration in septic shock patients.

Main Methods:

• In vitro leukocyte stimulation with norepinephrine and vasopressin.
• In vivo studies in mice using norepinephrine or vasopressin infusion followed by LPS challenge or cecal ligation and puncture.
• Clinical studies involving healthy volunteers receiving infusions and LPS challenge, and septic shock patients.

Main Results:

• Norepinephrine attenuated pro-inflammatory mediators and reactive oxygen species while increasing IL-10 production in vitro and in LPS-challenged mice.
• Norepinephrine infusion during cecal ligation and puncture led to increased bacterial dissemination in mice.
• In humans, norepinephrine enhanced IL-10 and attenuated IFN-γ-induced protein 10; vasopressin had no immunomodulatory effects.
• Higher norepinephrine rates correlated with anti-inflammatory cytokine balance, while beta-blocker use associated with pro-inflammatory balance in septic shock patients.

Conclusions:

• Norepinephrine dysregulates the immune response in both animal models and humans, potentially compromising host defense.
• Norepinephrine may contribute to sepsis-induced immunoparalysis.
• Vasopressin does not exhibit adverse immunologic effects, presenting a potentially safer alternative in septic shock.